Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity

Ginekologia Polska

Volumn 85, Issue 10, 2014, Pages 765-770

  Kozakowski, Jarosław ^a   Kapuścińska, Renata ^a   Zgliczyński, Wojciech ^a  

^a BIELANSKI HOSPITAL   (Poland)

Author keywords

Abdominal obesity; Gynoidal obesity; Polycystic ovary syndrome; Vitamin D

Indexed keywords

25-HYDROXYVITAMIN D; ANDROGEN; GLUCOSE BLOOD LEVEL; LEPTIN; SEX HORMONE BINDING GLOBULIN; VITAMIN D;

ADULT; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OVARY POLYCYSTIC DISEASE; VITAMIN D DEFICIENCY; YOUNG ADULT;

ADULT; ANDROGENS; BLOOD GLUCOSE; FEMALE; HUMANS; LEPTIN; METABOLIC SYNDROME X; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; SEX HORMONE-BINDING GLOBULIN; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84922480899     PISSN: 00170011     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Semmler EJ, Holick MF, Schnoes HK, DeLuca HF. The synthesis of 1a, 25-dihydroxycholecalciferol: a metabolically active form of vitamin D3. Tetrahedron Lett. 1972, 40, 4147-4150
2. Baker AR, McDonnell DP, Hughes M, [et al.]. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA. 1988, 85, 3294-3298.
3. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev. 1992, 13, 719-764.
4. Mahmoudi T. Genetic variation in the vitamin D receptor and polycystic ovary syndrome risk. Fertil Steril. 2009, 92, 1381-1383.
5. Thomson RL, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012, 77, 343-350.
6. Yildizhan R, Kurdoglu M, Adali E, [et al.]. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet. 2009, 280, 559-563.
7. Li HW, Brereton RE, Anderson RA, [et al.]. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metabolism. 2011, 60, 1475-1481.
8. Hahn S, Haselhorst U, Tan S, [et al.]. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2006, 114, 577-583.
9. Thys-Jacobs S, Donovan D, Papadopoulos A, [et al.]. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids. 1999, 64, 430-435.
10. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr. 2005, 94, 483-492.
11. Selimoglu H, Duran C, Kiyici S, [et al.]. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest. 2010, 33, 234-238.
12. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril. 2009, 92, 1053-1058.
13. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome. Fertil Steril. 2004, 81, 19-25.
14. Rissanen P, Hamalainen P, Vanninen E, [et al.]. Relationship of metabolic variables to abdominal adiposity measured by different anthropometric measurements and dual-energy X-ray absorptiometry in obese middle-aged women. Int J Obes Relat Metab Disord. 1997, 21, 367-371.
15. Carmina E, Bucchieri S, Esposito A, [et al.]. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extend of its relation to insulin resistance. J Clin Endocrinol Metab. 2007, 92, 2500-2505
16. Muscogiuri G, Policola C, Prioletta A, [et al.]. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr. 2012, 31, 476-480.
17. Wehr E, Pilz S, Schweighofer N, [et al.]. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009, 161, 575-582.
18. Brzozowska M, Karowicz-Bilinska A. The role of vitamin D deficiency in the etiology of polycystic ovary syndrome disorders. Ginekol Pol. 2013, 84, 456-460.
19. Lagunova Z, Porojnicu AC, Lindberg F, [et al.]. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res. 2009, 29, 3713-3720.
20. Kremer R, Campbell PP, Reinhardt T, Gilsanz V. Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab. 2009, 94, 67-73.
21. Young KA, Engelman CD, Langefeld CD, [et al.]. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab. 2009, 94, 3306-3313.
22. Kang JH, Kim SS, Moon SS, [et al.]. Adiposity in the relationship between serum vitamin d level and insulin resistance in middle-aged and Elderly Korean adults: The Korea National Health and Nutrition Examination Survey 2008. Endocrinol Metab (Seoul). 2013, 28, 96-102.